Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Exchange: NASDAQ CM
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Drug Delivery Systems

Oramed Pharmaceuticals Inc

+ Add to Watchlist

ORMP:US

8.6000 USD 0.1100 1.30%

As of 20:10:00 ET on 05/17/2013.

Company Profile for Oramed Pharmaceuticals Inc (ORMP)

Oramed Pharmaceuticals, Inc. is a pharmaceutical company focused on the development of oral delivery solution. The Company is developing orally ingestible insulin capsules for the treatment diabetes as well as delivery solutions for other drugs and vaccines.

Contact Information

Oramed Pharmaceuticals Inc

Givat Ram, Hi-tech Park 2/5
PO Box 39098
Jerusalem, 91390
Israel
Phone: 972-2-566-0001
Fax: 972-2-566-0004

Key Executives for Oramed Pharmaceuticals Inc (ORMP)

Nadav KidronPresident/CEOYifat ZommerCFO/Treasurer/Secretary
Miriam KidronCTO/Chief Medical OfcrJoshua Hexter "Josh"VP:Business Dev/COO
Ehud ArbitDirector:Research & DevAviva ShermanInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil